Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Summary of Meeting Memorandum - Anascorp


Our Reference: CRMTS #7517                                               Division of Blood Applications
                     BL 125335/0                                                 Telephone: (301) 827-3524
Instituto Bioclon, S.A. de C.V.
Attention: ----------(b)(4)------------
C/O --------(b)(4)--------
Dear -----(b)(4)------:
Attached is a copy of the memorandum summarizing your July 15, 2010, Type C meeting with CBER. Please note that although cited as attachments to the summary, we did not include copies of materials you supplied. This memorandum constitutes the official record of the meeting. If your understanding of the outcomes differs from those expressed in this meeting summary, it is your responsibility to bring these discrepancies to CBER’s attention for resolution.
If you have any questions, please contact Debbie Cordaro at (301) 827-6157.
Sincerely yours, 
Alan E. Williams, Ph.D.
Associate Director for Regulatory Affairs
Acting Chief, Regulatory Project
 Management Branch
Office of Blood Research and Review
Center for Biologics
 Evaluation and Research

Page Last Updated: 03/25/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English